Chapter 57 - Weight Loss Flashcards
Overweight BMI
25 - 29.9 kg/m2
Obese BMI
> = 30 Kg/ m2
BMI formula
Weight (KG) / Height 2 (m2)
- Anti psychotics (clozapine, olanzapine, risperidone, quetiapine)
- Diabetes drugs (insulin, meglitinides, sulfonylureas, thiazolidinediones)
- Divalproex/valproic acid
- Gabapentin, pregabalin Lithium
- Mirtazapine
- Steroids
- TCAs (amitriptyline, nortriptyline)
- Conditions: Hypothyroidism
Others:
- Beta-blockers Dronabinol
- Hormones (e.g., estrogen, megestrol)
- MAO inhibitors
- SSRls (paroxetine, others may be weight neutral)
- Vasodilators (e.g., minoxidil)
Treatment principles - Lifestyle modifications
- Reduced calorie (daily deficit ~500 - 750 kcal)
- Mediterranean, DASH, low-carb, low-fat, volumetric, high protein and vegetarian diets.
- Physical activity should increase to >= 150 minutes per week, performed on three to five separate days
- Behavioral Interventions
OTC SUPPLEMENTS
- Stimulants: bitter orange
- Excessive amounts of caffeine
– yerba mate
– guarana
– concentrated green tea powder - Generally ineffective and are not recommended, as they can be harmful, especially in patients with cardiovascular disease
PRESCRIPTION WEIGHT LOSS MEDICATIONS:
- Indication
- What drugs are used short term and for long term (maintenance)
- What drugs are removed from the US market and why?
- When should weight loss drugs be discontinued?
- They are indicated with a BMI >= 30 kg/m2, or BMI >= 27kg/m2 + at least one weight- related condition, such as dyslipidemia, hypertension or diabetes
- Older stimulant drugs (phentermine, diethylpropion) are only used short-term to “jump-start” a diet.
- The newer drugs Qsymia, Contrave, Saxenda and the orlistat formulations can be continued long-term for weight maintenance.
- Lorcaserin (Belviq,BelviqXR), a serotonin 5-HT2C receptor agonist, has been withdrawn from the U.S. market due to an increased risk of cancer.
- Weight loss drugs should be discontinued if they do not produce at least a 5% weight loss at 12weeks_
SELECT DRUGS/CONDITIONS THAT CAN CAUSE WEIGHT LOSS
- ADHD drugs (amphetamine, methylphenidate)
- Bupropion
- GLP-1 agonists (exenatide, liraglutide(Victoza))
- Pramlintide
- Roflumilast
- SGLT2 inhibitors (canagliflozin, empagliflozin)
- Topiramate
Conditions:
- Hyperthyroidism
- Celiac disease
- Inflammatory bowel disease
Others:
- Acetylcholinesterase inhibitors (e.g.,donepezil, rivastigmine, galantamine)
- Antiepileptic ethosuximide)
- Interferons
- Thyroid drugs (e.g., levothyroxine)
Conditions:
- Cystic fibrosis
- GERD or peptic ulcer disease
- Lupus
- Tuberculosis (active disease)
Rx drugs and Pregnancy:
Avoid all weight loss drugs
Rx drugs and HTN:
Avoid:
- Contrave (Naltrexone/ Bupropion): contraindicated with uncontrolled BP (contains bupropion)
Caution
- Qsymia (Phentermine/ Topiramate): monitor HR (contains phentermine)
Rx Drugs and Depression
Caution in young adults and adolescents
- Contrave - suicide risk
(contains bupropion)
Rx drugs and SEIZURES
Avoid
Contrave- lowers seizure threshold (contains bupropion)
Caution
Qsymia- must taper off slowly if used (contains topiramate)
Rx drugs and taking opioids
Avoid
Contrave- blocks opioid receptors (contains naltrexone)
Phentermine and Topiramate MOA
- Phentermine: sympathomimetic (stimulant); release of norepinephrine stimulates the satiety center which dec appetite
- Topiramate: inc satiety and dec appetite, possibly by inc GABA, blocking glutamate receptors and/or inhibition of carbonic anhydrase
Phentermine/Topiramate ER:
- Brand?
- Control?
- REMS Why?
(Qsymia)
C-IV
REMS drug due to teratogenic risk; pregnancy test needed before treatment and monthly thereafter; use effective contraception during treatment